Mark Sowden
Concepts (181)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
RNA Editing | 20 | 1996 | 10 |
Why?
| Apolipoproteins B | 22 | 1996 | 18 |
Why?
| Cytidine Deaminase | 18 | 1996 | 15 |
Why?
| RNA, Messenger | 18 | 1989 | 394 |
Why?
| Uridine | 4 | 1998 | 23 |
Why?
| Alternative Splicing | 2 | 2002 | 51 |
Why?
| Rats | 20 | 1996 | 530 |
Why?
| Molecular Sequence Data | 15 | 1989 | 404 |
Why?
| Cytidine | 3 | 1998 | 7 |
Why?
| Base Sequence | 15 | 1989 | 371 |
Why?
| Hepatocytes | 3 | 2001 | 42 |
Why?
| RNA-Binding Proteins | 2 | 2002 | 55 |
Why?
| Genetic Variation | 1 | 2003 | 91 |
Why?
| Cell Compartmentation | 2 | 2000 | 37 |
Why?
| Tumor Cells, Cultured | 11 | 1996 | 233 |
Why?
| RNA Splicing | 2 | 1996 | 42 |
Why?
| Liver | 8 | 1996 | 248 |
Why?
| Methyltransferases | 1 | 1999 | 18 |
Why?
| Animals | 24 | 1996 | 1031 |
Why?
| Amino Acid Sequence | 8 | 1996 | 319 |
Why?
| DNA Primers | 7 | 1996 | 208 |
Why?
| RNA | 4 | 1996 | 126 |
Why?
| Heterogeneous-Nuclear Ribonucleoproteins | 2 | 2006 | 8 |
Why?
| Cell Nucleus | 5 | 2000 | 169 |
Why?
| Recombinant Proteins | 4 | 1996 | 290 |
Why?
| Betaine-Homocysteine S-Methyltransferase | 2 | 1999 | 4 |
Why?
| Cytoplasm | 2 | 2000 | 108 |
Why?
| Leukopoiesis | 1 | 2011 | 6 |
Why?
| Granulocyte Colony-Stimulating Factor | 1 | 2011 | 34 |
Why?
| Granulocytes | 1 | 2011 | 46 |
Why?
| Viral Proteins | 2 | 1989 | 71 |
Why?
| Sequence Homology, Amino Acid | 4 | 2002 | 156 |
Why?
| Cloning, Molecular | 4 | 1989 | 183 |
Why?
| Phospholipid Transfer Proteins | 1 | 2011 | 3 |
Why?
| Bovine papillomavirus 1 | 2 | 1989 | 6 |
Why?
| Introns | 3 | 1996 | 58 |
Why?
| Sequence Homology, Nucleic Acid | 2 | 1998 | 88 |
Why?
| Rats, Sprague-Dawley | 5 | 1997 | 257 |
Why?
| Enhancer Elements, Genetic | 2 | 1989 | 43 |
Why?
| Ethanol | 2 | 1998 | 58 |
Why?
| Saccharomyces cerevisiae | 3 | 1989 | 67 |
Why?
| Transcription, Genetic | 5 | 1989 | 253 |
Why?
| Escherichia coli | 3 | 1996 | 143 |
Why?
| Liver Neoplasms, Experimental | 3 | 1996 | 21 |
Why?
| Transfection | 3 | 1996 | 237 |
Why?
| Gene Expression | 4 | 1996 | 291 |
Why?
| Gene Expression Regulation | 2 | 1989 | 277 |
Why?
| Papillomaviridae | 1 | 1989 | 37 |
Why?
| Cell Proliferation | 1 | 2011 | 227 |
Why?
| Humans | 16 | 1996 | 1856 |
Why?
| Protein Structure, Tertiary | 3 | 2001 | 163 |
Why?
| Carcinoma, Hepatocellular | 2 | 1996 | 53 |
Why?
| Lipoproteins | 2 | 1996 | 52 |
Why?
| Active Transport, Cell Nucleus | 2 | 2001 | 55 |
Why?
| Lipoproteins, VLDL | 1 | 2006 | 7 |
Why?
| Cells, Cultured | 5 | 1998 | 447 |
Why?
| Phylogeny | 1 | 2006 | 63 |
Why?
| Cell Line | 5 | 1996 | 375 |
Why?
| Genes, env | 2 | 2001 | 8 |
Why?
| Protein Folding | 1 | 2004 | 30 |
Why?
| DNA, Single-Stranded | 1 | 2004 | 32 |
Why?
| Molecular Weight | 1 | 2003 | 154 |
Why?
| Transcription Factors | 1 | 1989 | 201 |
Why?
| Sequence Alignment | 4 | 1996 | 114 |
Why?
| DNA, Complementary | 2 | 1999 | 139 |
Why?
| Cytosine | 1 | 2002 | 20 |
Why?
| Spliceosomes | 1 | 2001 | 7 |
Why?
| Hyperinsulinism | 2 | 1996 | 10 |
Why?
| Nuclear Localization Signals | 1 | 2001 | 16 |
Why?
| Protein Isoforms | 1 | 2002 | 86 |
Why?
| Mammals | 2 | 1996 | 47 |
Why?
| Rabbits | 2 | 1998 | 252 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 243 |
Why?
| Saccharomyces cerevisiae Proteins | 1 | 2004 | 58 |
Why?
| Oligodeoxyribonucleotides | 2 | 1996 | 86 |
Why?
| Intestines | 1 | 1999 | 83 |
Why?
| Diabetes Mellitus, Experimental | 1 | 1998 | 36 |
Why?
| Hyperglycemia | 1 | 1998 | 31 |
Why?
| Genetic Techniques | 1 | 1998 | 27 |
Why?
| Stearic Acids | 1 | 1997 | 7 |
Why?
| Oleic Acid | 1 | 1997 | 14 |
Why?
| Alleles | 1 | 1998 | 108 |
Why?
| Species Specificity | 1 | 1998 | 186 |
Why?
| DCMP Deaminase | 1 | 1996 | 2 |
Why?
| Polymerase Chain Reaction | 2 | 1996 | 279 |
Why?
| Glucuronidase | 1 | 1996 | 26 |
Why?
| Consensus Sequence | 1 | 1996 | 39 |
Why?
| Liver Neoplasms | 1 | 1998 | 97 |
Why?
| Recombinant Fusion Proteins | 3 | 1999 | 189 |
Why?
| Nephrotic Syndrome | 1 | 1996 | 16 |
Why?
| Apolipoprotein A-I | 1 | 1996 | 19 |
Why?
| Male | 6 | 1996 | 1553 |
Why?
| Regulatory Sequences, Nucleic Acid | 1 | 1996 | 43 |
Why?
| Proteins | 2 | 1996 | 192 |
Why?
| Insulin | 1 | 1998 | 129 |
Why?
| Promoter Regions, Genetic | 3 | 1989 | 188 |
Why?
| Models, Molecular | 2 | 2004 | 102 |
Why?
| Phosphorylation | 2 | 2006 | 224 |
Why?
| Mutagenesis, Site-Directed | 2 | 2001 | 126 |
Why?
| Obesity | 1 | 1996 | 149 |
Why?
| Myeloid Progenitor Cells | 1 | 2011 | 6 |
Why?
| Mice | 3 | 2003 | 623 |
Why?
| Mitosis | 1 | 2011 | 68 |
Why?
| Neurofibromin 1 | 2 | 1996 | 3 |
Why?
| Genes, Viral | 1 | 1989 | 37 |
Why?
| Neutrophils | 1 | 2011 | 114 |
Why?
| Mutation | 2 | 2004 | 340 |
Why?
| Rats, Zucker | 2 | 1996 | 7 |
Why?
| Mice, Knockout | 1 | 2011 | 265 |
Why?
| Takifugu | 1 | 2006 | 7 |
Why?
| Nuclear Export Signals | 1 | 2006 | 7 |
Why?
| NIH 3T3 Cells | 1 | 2006 | 22 |
Why?
| Growth and Development | 1 | 2006 | 4 |
Why?
| Sterol Regulatory Element Binding Proteins | 1 | 2006 | 4 |
Why?
| Betaine | 1 | 2006 | 6 |
Why?
| Leucine | 1 | 2006 | 53 |
Why?
| Phosphoprotein Phosphatases | 1 | 2006 | 21 |
Why?
| Immunoglobulin Class Switching | 1 | 2006 | 17 |
Why?
| Catalytic Domain | 1 | 2006 | 27 |
Why?
| Methionine | 1 | 2006 | 38 |
Why?
| Xenopus Proteins | 1 | 2006 | 15 |
Why?
| Protein Kinases | 1 | 2006 | 64 |
Why?
| Enzyme Induction | 1 | 2006 | 64 |
Why?
| Protein Transport | 1 | 2006 | 101 |
Why?
| HeLa Cells | 1 | 2006 | 107 |
Why?
| Xenopus laevis | 1 | 2006 | 49 |
Why?
| Phosphoproteins | 1 | 2006 | 86 |
Why?
| Deamination | 1 | 2004 | 3 |
Why?
| Diet | 1 | 2006 | 87 |
Why?
| Enzyme Activation | 1 | 2006 | 177 |
Why?
| Somatic Hypermutation, Immunoglobulin | 1 | 2004 | 8 |
Why?
| RNA Stability | 1 | 2006 | 38 |
Why?
| Immunoglobulin M | 1 | 2004 | 81 |
Why?
| Crystallography, X-Ray | 1 | 2004 | 41 |
Why?
| Syndrome | 1 | 2004 | 142 |
Why?
| Enzyme Inhibitors | 1 | 2006 | 216 |
Why?
| DNA-Binding Proteins | 1 | 1989 | 204 |
Why?
| RNA Processing, Post-Transcriptional | 1 | 2004 | 33 |
Why?
| Quality Control | 1 | 2003 | 54 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2006 | 119 |
Why?
| Protein Conformation | 1 | 2004 | 123 |
Why?
| Cell Culture Techniques | 1 | 2003 | 74 |
Why?
| Emetine | 1 | 2001 | 6 |
Why?
| Nucleic Acid Synthesis Inhibitors | 1 | 2001 | 11 |
Why?
| Dactinomycin | 1 | 2001 | 40 |
Why?
| Protein Synthesis Inhibitors | 1 | 2001 | 33 |
Why?
| Cell Fractionation | 1 | 2001 | 42 |
Why?
| Binding Sites | 1 | 2004 | 213 |
Why?
| Genetic Complementation Test | 1 | 2001 | 38 |
Why?
| Cell Cycle | 1 | 2003 | 121 |
Why?
| Fatty Acids, Unsaturated | 1 | 2001 | 22 |
Why?
| Exons | 1 | 2002 | 91 |
Why?
| Antibiotics, Antineoplastic | 1 | 2001 | 35 |
Why?
| Macromolecular Substances | 1 | 2001 | 92 |
Why?
| Genes, Reporter | 1 | 2001 | 111 |
Why?
| Aging | 1 | 2006 | 275 |
Why?
| Subcellular Fractions | 1 | 2000 | 67 |
Why?
| Luminescent Proteins | 1 | 1999 | 67 |
Why?
| Postprandial Period | 1 | 1998 | 14 |
Why?
| Green Fluorescent Proteins | 1 | 1999 | 105 |
Why?
| Genes, Wilms Tumor | 1 | 1998 | 4 |
Why?
| Organ Size | 1 | 1998 | 118 |
Why?
| DNA Ligases | 1 | 1998 | 7 |
Why?
| Evaluation Studies as Topic | 1 | 1998 | 178 |
Why?
| Body Weight | 1 | 1998 | 178 |
Why?
| Immunohistochemistry | 1 | 2001 | 355 |
Why?
| Point Mutation | 1 | 1998 | 122 |
Why?
| Hydroxymethylglutaryl CoA Reductases | 1 | 1996 | 4 |
Why?
| Hypertriglyceridemia | 1 | 1996 | 14 |
Why?
| Polymorphism, Genetic | 1 | 1998 | 94 |
Why?
| Animals, Genetically Modified | 1 | 1996 | 29 |
Why?
| Insulin Resistance | 1 | 1996 | 37 |
Why?
| Cholesterol | 1 | 1996 | 86 |
Why?
| Lipids | 1 | 1996 | 97 |
Why?
| Dose-Response Relationship, Drug | 1 | 1998 | 431 |
Why?
| Phospholipids | 1 | 1996 | 52 |
Why?
| Sensitivity and Specificity | 1 | 1998 | 427 |
Why?
| DNA | 1 | 1998 | 262 |
Why?
| Disease Models, Animal | 1 | 1996 | 349 |
Why?
| Interferon Type I | 1 | 1989 | 22 |
Why?
| DNA, Fungal | 1 | 1989 | 27 |
Why?
|
|
Sowden's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
